Re: Zenith Epigenetics Ltd. Announces Collaboration with Cencora on ZEN-3694

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith Epigenetics Ltd. Announces Collaboration with Cencora on ZEN-3694

in response to

Re: Zenith Epigenetics Ltd. Announces Collaboration with Cencora on ZEN-3694

fuzzyjr

posted on Oct 26, 2023 12:41PM

ZHCLF @ $0.12 US.......with 13 Clinical trials ongoing.

That equates to about $0.01 US per Clinical trial. What a deal!

Then there are up-and-coming biotech stocks struggling to get going with one clinical trial with a share price, 10-20 times ZHCLF's share price. Nonsensical!